Crowdsourcing to promote hepatitis C testing and linkage-to-care in China: a randomized controlled trial protocol
William C.W. Wong(University of Hong Kong - Shenzhen Hospital), Joseph D. Tucker(University of North Carolina at Chapel Hill), Thomas Fitzpatrick(University of Washington), Polin Chan(Western University), Weiming Tang(University of North Carolina at Chapel Hill), Nancy Yang(University of Minnesota Medical Center), Yuan Xiong(University of North Carolina at Chapel Hill), Jingjing Li, Hang Li(University of Hong Kong - Shenzhen Hospital), Eric Yuk Fai Wan(Nano and Advanced Materials Institute), Wai‐Kay Seto(State Key Laboratory of Synthetic Chemistry), Ruihong Liu(University of Hong Kong - Shenzhen Hospital)
Cited by 6
Related Papers
Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19
|Radiology|2020|1.5k
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
|Journal of Infection|2020|1.2k
Signaling Pathways that Control Cell Proliferation
|Cold Spring Harbor Perspectives in Biology|2013|371
Global reporting of progress towards elimination of hepatitis B and hepatitis C
|The Lancet. Gastroenterology & hepatology|2023|323
Hepatitis B virus infection in children and adolescents
|The Lancet. Gastroenterology & hepatology|2019|258